ReviewClinical rheumatology2026
Paget's disease of bone in a North African population: clinical, imaging, and therapeutic insights from a Moroccan case series.
Review in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPaget's disease of bone (PDB) is a non-malignant skeletal disease that has become rare in recent decades. It is characterized by disorganized bone remodeling. Although its presentation varies worldwide, it is infrequently reported in Africans. To our knowledge, this is the first case series of PDB reported from Morocco, highlighting clinical and imaging features in a North African population.
methodsA retrospective case series and a literature review. Seven patients were identified during an 8-year period and diagnosed with Paget's disease of bone. Demographic profiles, clinical presentations, laboratory tests, imaging features and therapeutic approaches were collected and analyzed.
resultsThe mean age of the seven patients (4 women and 3 men) at disease diagnosis was 60.5. The most affected sites were the spine and the skull. One patient had a monostotic form. Neurological complications were observed in three patients, including blindness due to optic nerve compression and profound hearing loss requiring cochlear implantation. One patient had concurrent bladder cancer, making the differential diagnosis challenging. Six patients had vitamin D deficiency or insufficiency. All patients received intravenous zoledronic acid, with significant clinical and biochemical improvement in the majority of cases. No malignant transformation was observed during follow-up.
conclusionIn this Moroccan series, incidental diagnosis was common and skull/spine involvement predominated, consistent with prior literature. The severity of neurological complications highlights the importance of early recognition and prompt metabolic management in comparable settings. Key Points • Clinical spectrum of Paget's disease of bone in a North African population. • Neurological complications and sensory impairments in Paget's disease. • Imaging features including a "cotton wool" appearance and diagnostic challenges. • Therapeutic outcomes of intravenous zoledronic acid in Paget's disease.
Indexed as
Identifiers
41526553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.